Sulfo-SMCC, amine-to-sulfhydryl crosslinking agent (ab145607)
Key features and details
- Amine-to-sulfhydryl crosslinking agent
- CAS Number: 92921-24-9
- Purity: > 90%
- Soluble in water to 10 mM
- Form / State: Solid
- Source: Synthetic
Overview
-
Product name
Sulfo-SMCC, amine-to-sulfhydryl crosslinking agent -
Description
Amine-to-sulfhydryl crosslinking agent -
Purity
> 90% -
General notes
This product is manufactured by BioVision, an Abcam company and was previously called 2320 Sulfo-SMCC. 2320-100 is the same size as the 100 mg size of ab145607.
-
CAS Number
92921-24-9 -
Chemical structure
Properties
-
Chemical name
1-[4-[(2,5-Dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]oxy-2,5-dioxopyrrolidine-3-sulfonate sodium salt -
Molecular weight
436.37 -
Molecular formula
C16H17N2NaO9S -
PubChem identifier
4618794 -
Storage instructions
Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months. -
Solubility overview
Soluble in water to 10 mM -
Handling
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Refer to SDS for further information.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
SMILES
C1CC(CCC1CN2C(=O)C=CC2=O)C(=O)ON3C(=O)CC(C3=O)S(=O)(=O)[O-].[Na+] -
Source
Synthetic
-
Research areas
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (1)
ab145607 has been referenced in 1 publication.
- Li B et al. Molecularly engineered truncated tissue factor with therapeutic aptamers for tumor-targeted delivery and vascular infarction. Acta Pharm Sin B 11:2059-2069 (2021). PubMed: 34386338